PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Ondansetron hydrochloride - Nausea and vomiting (post operative)
PAD Profile : Ondansetron hydrochloride - Nausea and vomiting (post operative)
Traffic Light Status
Status 1 of 3.
Status :
Red
Important
Formulations :
- Injection
- Oral solution
- Tablets
Important Information :
Oral solution reserved for use when tablets are not suitable.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 3.
Status :
Red
Important
Formulations :
- Oro-dispersible
- Orodispersible films
Important Information :
Orodispersible preparations reserved for use when ordinary tablets are not suitable.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 3 of 3.
Guidelines
No guidelines returned.
Other Drugs
- Cyclizine hydrochloride
- Metoclopramide hydrochloride
- Prochlorperazine maleate
- Droperidol
- Dexamethasone
- Granisetron
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
06 November 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
04. Central Nervous System
04.06.00. Drugs used in nausea and vertigo